DrugDashboards

Solu-Cortef

hydrocortisone sodium succinate · HYDROCORTISONE SODIUM SUCCINATE 100 mg/2mL · Injection, Powder, For Solution · Intramuscular; Intravenous · ProPharma Distribution

NDC 84549-0011-04 · 2 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. A shortage here was resolved within the past year — markets usually stay tight for a while after. Historically, drugs in this position went on to a new shortage within 90 days about 0.6% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for hydrocortisone sodium succinate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $73.96 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA009866
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

  • Shortage ended — Solu-cortef, Injection, 100 mg/vial (NDC 0009-0011-04)Mar 24, 2023 → Feb 24, 2026
  • Shortage ended — Solu-cortef, Injection, 100 mg/vial (NDC 0009-0825-01)Mar 24, 2023 → Feb 24, 2026
  • Shortage ended — Solu-cortef, Injection, 1000 mg/vial (NDC 0009-0005-01)Mar 24, 2023 → Feb 24, 2026
  • Shortage ended — Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05)Mar 24, 2023 → Feb 24, 2026
  • Shortage ended — Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-06)Mar 24, 2023 → Feb 24, 2026
  • Shortage ended — Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12)Mar 24, 2023 → Feb 24, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of hydrocortisone sodium succinate (Injection, Powder, For Solution)

LabelerStrengthFirst seenLast seen
Apotex Corp.HYDROCORTISONE SODIUM SUCCINATE 100 mg/2mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCHYDROCORTISONE SODIUM SUCCINATE 100 mg/2mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCHYDROCORTISONE SODIUM SUCCINATE 250 mg/2mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCHYDROCORTISONE SODIUM SUCCINATE 500 mg/4mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCHYDROCORTISONE SODIUM SUCCINATE 1000 mg/8mLJul 15, 2026Sep 2, 2026
ProPharma DistributionHYDROCORTISONE SODIUM SUCCINATE 100 mg/2mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCHYDROCORTISONE SODIUM SUCCINATE 100 mg/2mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Solu-Cortef — NDC 84549-0011-04," retrieved September 3, 2026, https://drugdashboards.com/drug/84549001104.

Free to cite with attribution — see how the data is put together.